Long-term Safety of Protopic in Atopic Eczema

PHASE3CompletedINTERVENTIONAL
Enrollment

789

Participants

Timeline

Start Date

June 30, 1998

Study Completion Date

June 30, 2005

Conditions
Dermatitis, AtopicEczema, Atopic
Interventions
DRUG

Tacrolimus ointment 0.1%

Topical

Trial Locations (41)

Unknown

Brussels

Aarhus

Helsinki

Tampere

Turku

Bordeaux

Brest

Gaël

Lyon

Nantes

Paris

Pessac

Quimper

Saint-Etienne

Tours

Bonn

Düsseldorf

Erlangen

Freiburg im Breisgau

Hamburg

Hanover

München

Münster

Tübingen

Szeged

Cork

Dublin

Riga

Amsterdam

Warsaw

Barcelona

Madrid

Seville

Cardiff

Coventry

Lancaster

Leicester

Liverpool

London

Manchester

Southhampton

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY